Rose Higgins to Lead Strategic and Day-to-Day Operations, Driving the Next Stage of Growth.
In April of 2022, our CEO and Co-founder Bob Battista participated in a meeting hosted by The London School of Economics and Political Science, of cross-sectoral stakeholders on the topic, “Paying the Pandemic Piper: Global Health and Economic Security,” which resulted in an impactful proposal published in The Lancet.
Dr.Evidence™ Partners with MedShr™ to Enhance Medical Knowledge for Physicians and Healthcare Professionals (HCPs)
Doctor Evidence (DRE) and The Castleman Disease Collaborative Network (CDCN) Announce Collaboration
Doctor Evidence, LLC (“DRE”) Expands Medical Strategy Advisory Board to Strengthen its Artificial Intelligence Solution in Drug Discovery
DRE’s DOC Analytics™ Generates First-Ever Automated Network Meta-Analysis with Natural Language Question AI-Powered Search Results
Dr.Evidence™ announces the appointment of Michael J. Klag, MD, MPH to its medical strategy advisory board